These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14511567)

  • 1. Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses.
    Liu Z; Panousis C; Smyth FE; Murphy R; Wirth V; Cartwright G; Johns TG; Scott AM
    Hybrid Hybridomics; 2003 Aug; 22(4):219-28. PubMed ID: 14511567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
    Boghaert ER; Sridharan L; Armellino DC; Khandke KM; DiJoseph JF; Kunz A; Dougher MM; Jiang F; Kalyandrug LB; Hamann PR; Frost P; Damle NK
    Clin Cancer Res; 2004 Jul; 10(13):4538-49. PubMed ID: 15240546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualification and application of a surface plasmon resonance-based assay for monitoring potential HAHA responses induced after passive administration of a humanized anti Lewis-Y antibody.
    Szolar OH; Stranner S; Zinoecker I; Mudde GC; Himmler G; Waxenecker G; Nechansky A
    J Pharm Biomed Anal; 2006 Jun; 41(4):1347-53. PubMed ID: 16644171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
    Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
    J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen.
    Thanavala YM; Bond A; Tedder R; Hay FC; Roitt IM
    Immunology; 1985 Jun; 55(2):197-204. PubMed ID: 2408999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO.
    Siebert N; Eger C; Seidel D; Jüttner M; Lode HN
    J Immunol Methods; 2014 May; 407():108-15. PubMed ID: 24727144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
    Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
    J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
    Krug LM; Milton DT; Jungbluth AA; Chen LC; Quaia E; Pandit-Taskar N; Nagel A; Jones J; Kris MG; Finn R; Smith-Jones P; Scott AM; Old L; Divgi C
    J Thorac Oncol; 2007 Oct; 2(10):947-52. PubMed ID: 17909358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
    Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of anti-idiotype antibodies to human monoclonal antibody].
    Harada R; Takahashi N; Owaki I; Kannagi R; Endo N; Morita N; Inoue M
    Igaku Kenkyu; 1992 Feb; 62(1):1-18. PubMed ID: 1523940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis for altered idiotype expression in the hyperimmune response to (4-hydroxy-3-nitrophenyl)acetyl hapten.
    White-Scharf ME; Imanishi-Kari T
    J Immunol; 1986 Aug; 137(3):887-96. PubMed ID: 3088116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
    Kelly MP; Lee FT; Tahtis K; Smyth FE; Brechbiel MW; Scott AM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5604s-5612s. PubMed ID: 17875796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and biological properties of hybridoma cell lines secreting anti-IBDV idiotypic antibodies].
    Zhu RL; Cui ZZ; Zhao J
    Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):462-6. PubMed ID: 15969065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.
    Phillips ML; Harris JF; Delovitch TL
    J Immunol; 1984 Nov; 133(5):2587-94. PubMed ID: 6434633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotype-anti-idiotype interactions and the control of the anti-beta (2 leads to 6) polyfructosan response in the mouse: specificity and idiotypy of anti-ABPC48 anti-idiotypic monoclonal antibodies.
    Legrain P; Voegtle D; Buttin G; Cazenave PA
    Eur J Immunol; 1981 Sep; 11(9):678-85. PubMed ID: 7297596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
    Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
    Steinitz M; Tamir S; Frödin JE; Lefvert AK; Mellstedt H
    J Immunol; 1988 Nov; 141(10):3516-22. PubMed ID: 2846688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.